Cowen

In the athletic apparel industry, numerous higher-end brands have emerged on the women's side of the business, but men’s options have largely been relegated to Nike Inc (NYSE: NKE), Under Armour Inc (NYSE: UAA) and adidas AG (ADR) (OTC: ADDYY). These brands' price points are...

Strong promotional activity may be waning at Foot Locker, Inc. (NASDAQ: FL). The Analyst Cowen's John Kernan on Monday maintained a Market Perform rating and raised his price target from $46 to $56. The Thesis Cowen’s channel checks are showing significantly improved full-price selling...

Cowen offered five reasons to warrant a bullish rating on retailer Target Corporation (NYSE: TGT) after holding a neutral stance on the stock for more than two years. The Analyst Cowen's Oliver Chen upgraded Target from Market Perform to Outperform with a price target lifted from $90 to $100....

Under Armour Inc (NYSE: UAA) shares gained 27.71 percent to $23.23 Tuesday after the apparel maker reported a big third-quarter earnings beat. What Happened The Baltimore-based athletic apparel brand reported Q3 earnings of 25 cents per share, beating estimates by 12 cents. Under Armour sales...

Advanced Micro Devices, Inc. (NASDAQ: AMD) shares took a big hit in the aftermath of its quarterly results Wednesday, with the stock pulling back about 26 percent in three sessions. Following the "noisy" Q3 and "disappointing" Q4 guidance, an analyst at Cowen spent time with...

The influence of the Detroit-based sneaker marketplace StockX in footwear is accelerating, according to Cowen. StockX recently raised $44 million in Series B funding, which increases its potential for marketplace disruption, analyst John Kernan said in a Monday note. The funding round,...

Nike Inc (NYSE: NKE) shares were hit hard Wednesday after a sell-side analyst said the company's valuation feels rich after recently striking all-time highs. The Analyst Cowen analyst John Kernan maintained a Market Perform rating on Nike with a $81 price target. The Thesis...

Allogene Therapeutics is set to begin trading on the Nasdaq Stock Exchange under the ticker symbol “ALLO.” The stock is expected to debut Thursday, Oct. 11, although an official IPO date has not yet been released. The Details San Francisco-based Allogene intends to raise $288 million...

Lululemon Athletica inc. (NASDAQ: LULU) has been on a upward trajectory this year that should continue, Cowen said Tuesday following a meeting with CEO Calvin McDonald.  The Analyst  Cowen analyst John Kernan maintained an Outperform rating  on Lululemon and raised the...

Excitement around golf is on the upswing after Tiger Woods' comeback at the Tour Championship last week to close out the PGA Tour season. Callaway Golf Co (NYSE: ELY) may be reaping the benefits of a golf resurgence, particularly due to its Topgolf investment, according to Cowen.  The...

This weekend's Barron's shows why the midterm elections could boost health care stocks no matter the outcome. Other featured articles offer the Barron's Pick getting a lift from the emerging cannabis market and real estate stocks that are riding a retail comeback. Also, a toymaker...

Skechers USA Inc (NYSE: SKX) shares are down 27 percent year-to-date, but given the shoemaker's large valuation gap to peers, Cowen anticipates additional declines.  The Analyst  Cowen analyst John Kernan downgraded Skechers from Outperform to Market Perform and...

Apparel and footwear company VF Corp (NYSE: VFC) is emerging as a margin expansion story, according to Cowen. The Analyst Analyst John Kernan upgraded shares of VF Corp. from Market Perform to Outperform and increased the price target from $96 to $106. The Thesis VF Corp's 2023 guidance...

Cowen is taking a more constructive view on Canopy Growth Corp. (NYSE: CGC)'s early lead in the cannabis industry after a meeting with the marijuana company's management. The Analyst Cowen analyst Vivien Azer maintained an Outperform rating on Canopy Growth's Canadian stock ...

Lululemon Athletica (NASDAQ: LULU) demonstrated strong momentum in Q2, in light of improved product assortment and a new guest acquisition for online and in-store sales. The Analyst Cowen analyst John Kernan maintained an Outperform rating and raised the price target from $137 to $175. The Thesis...